ii
ocular
mucos
immunobiolog
tissu
cell
conjunctiva
lacrim
gland
primari
ocular
tissu
consid
part
mucos
immun
system
conjunctiva
mucou
membran
e
consist
outer
squamou
epitheli
cell
lay
r
mucos
vaccin
copyright
academ
press
inc
right
reproduct
anv
form
reser
v
ed
two
five
cell
thick
interspers
goblet
cell
basement
membran
underli
connect
tissu
substantia
propria
stroma
figur
diagram
major
featur
human
conjunctiva
bulbar
conjunctiva
overli
sclera
corneal
limbu
conjunctiv
fornix
multipl
e
sebac
gland
within
deeper
stroma
contribut
corneal
tear
film
lubric
conjunctiva
fine
yanoff
mast
cell
bee
n
identifi
conjunctiva
human
primat
sever
rodent
allansmith
et
fine
yanoff
particularli
promin
traumainduc
allerg
conjunct
microfold
cell
conjunctiva
normal
conjunctiva
rel
free
lymphocyt
howev
similar
gastrointestinalassoci
lymphoid
tissu
e
galt
intraepitheli
lymphocyt
iel
bee
n
identifi
human
mous
conjunctiva
dua
et
j
whittumhudson
unpublish
observ
human
conjunctiv
iel
cell
expr
mucos
lymphocyt
antigen
du
et
anoth
studi
found
major
f
conjunctiv
cell
express
lp
tcr
soukiasian
e
murin
equival
iel
tcr
j
whittumhudson
unpublish
observ
cell
essenti
b
cell
found
substantia
propria
normal
human
monkey
mous
conjunctiva
reacher
et
al
soukiasian
et
al
dua
et
whittumhudson
et
major
substantia
propria
lymphocyt
cell
man
monkey
li
e
subepitheli
lower
fornix
human
conjunctiva
cluster
unorgan
nonfollicular
lym
sack
et
al
phocyt
may
found
fine
yanoff
speci
rabbit
guinea
pig
may
exhibit
tru
e
follicl
lower
fornic
shimada
silverstein
chandler
gillett
may
develop
due
persist
exposur
exogen
antigen
reflect
nonspecif
respons
th
e
environ
lacrim
gland
also
play
major
role
ocula
r
mucos
defens
human
lacrim
gland
foun
anterior
superolater
area
orbit
smaller
accessori
lacrim
gland
see
fig
also
may
foun
upper
lower
conjunctiva
duct
major
lacrim
gland
drain
superotempor
conjunctiv
culdesac
duct
accessori
gland
drain
directli
epithelium
conjunctiv
adjac
locat
lacrim
gland
speci
found
differ
area
within
outsid
e
orbit
histolog
examin
show
th
e
gland
made
acinar
unit
interconnect
ductul
interconnect
acina
r
unit
form
lobe
gland
acinar
unit
consist
secretori
acinar
epitheli
cell
surround
basement
membran
glandula
r
duct
line
pseudostratifi
epithelium
lymphat
channel
also
present
gland
drain
cervic
preauricular
lymp
h
node
addit
epitheli
cell
varieti
oth
r
cell
type
plasma
cell
b
lymphocyt
macrophag
dendrit
cell
identifi
n
interstiti
connect
tissu
acina
r
unit
duct
human
rabbit
rat
mous
lacrim
gland
iga
plasma
cell
predomin
although
igg
igm
plasma
cell
present
human
ig
ige
plasma
cell
found
franklin
et
al
shimada
silverstein
allansmith
et
al
brandtzaeg
et
al
crago
et
al
damato
et
al
mcgee
franklin
gudmundsson
et
al
brandtzaeg
kett
et
al
wieczorek
et
al
ebersol
et
al
pappo
et
al
han
n
et
al
montgomeri
et
al
b
cell
bearin
g
variou
surfac
immunoglobulin
isotyp
also
bee
n
found
smaller
number
human
rodent
mcgee
franklin
pappo
et
al
wieczorek
et
al
montgomeri
et
al
montgomeri
et
al
pepos
et
al
cell
al
identifi
human
rat
ebersol
et
al
gudmundsson
et
al
wieczorek
et
al
pappo
et
al
pepos
et
al
montgomeri
et
al
montgomeri
et
al
cell
isol
rat
lacrim
gland
bear
ar
expr
tcr
c
skandera
p
c
montgomeri
unpublish
observ
macrophag
demonstr
human
rat
wieczorek
et
al
pappo
et
al
montgomeri
et
al
pepos
et
al
langerhanstyp
dendrit
cell
identifi
human
lacrim
gland
wieczorek
et
al
pepos
et
al
variou
cell
type
contribut
number
biolog
activ
molecul
whic
h
import
defens
ocular
surfac
th
e
acinar
epitheli
cell
produc
lysozym
lactoferri
n
natur
occur
tear
compon
wit
h
bactericid
properti
franklin
et
al
gillett
e
allansmith
gillett
et
al
mcgill
et
al
addit
plasma
cell
mai
n
sourc
tear
siga
antibodi
sullivan
allansmith
peppard
montgomeri
franklin
produc
n
respons
antigen
challeng
major
effecto
r
molecul
mucos
defens
childer
et
al
mcghee
mestecki
although
postul
conjunctiv
function
mucos
induct
effector
sit
e
chandler
gillett
franklin
remu
franklin
precis
relationship
th
e
conjunctiva
mucos
immun
network
requir
clarif
respect
induct
capabl
presenc
lymphoid
follicl
contain
b
cell
rabbit
shimada
silverstein
franklin
et
al
franklin
remu
human
presenc
langerhan
cell
dendrit
cell
macrophag
sack
et
al
well
lymphat
channel
srinivasan
et
al
support
potenti
process
perhap
respond
antigen
normal
conjunctiv
epitheli
cell
express
mhc
class
ii
howev
presenc
class
ii
langerhan
cell
epithelium
dendrit
cell
stroma
suggest
antigen
presentatio
n
may
occur
conjunctiva
support
induct
function
come
studi
show
topic
applic
antigen
conjunctiva
effect
mean
elicit
tear
iga
antibodi
respons
montgomeri
et
al
b
peppard
et
al
recent
investig
suggest
nasalassoci
lymphoid
tissu
nalt
may
also
function
induct
site
follow
ocular
topic
antigen
applicatio
n
carr
et
al
submit
see
section
iii
except
rabbit
conjunctiva
contain
substanti
number
iga
plasma
cell
epitheli
cell
tha
synthes
secretori
compon
franklin
et
al
franklin
et
al
liu
et
conjunctiva
speci
display
typic
featur
mucos
effector
site
howev
note
studi
least
two
speci
rat
monkey
document
lymphocyt
traffic
gastrointestinalassoci
lymphoid
tissu
galt
conjunctiva
zhang
et
al
taylor
et
al
data
indic
function
role
conjunctiva
mucos
networ
k
may
vari
significantli
speci
abund
evid
indic
th
e
lacrim
gland
function
part
mucos
im
mune
network
demonstr
mucos
effector
tissu
describ
see
sectio
n
ii
lacrim
gland
mani
speci
contain
predomin
iga
plasma
cell
addit
lacrim
acinar
epitheli
cell
produc
secretori
compon
franklin
et
al
sullivan
et
al
sullivan
et
al
gudmundsson
et
al
hann
et
al
function
part
polymer
immunoglobulin
recepto
r
mediat
transport
iga
extern
secret
solari
kraehenbuhl
figur
diagram
biosynthet
event
within
lacrim
gland
lead
th
e
product
transport
iga
tear
linkag
f
lacrim
gland
mucos
network
occur
vi
traffick
lymphocyt
popul
b
lymphocyt
traffic
mucos
tissu
includ
lacrim
gland
b
cell
studi
extensivel
cell
iga
bear
lymphocyt
galt
e
g
mesenter
lymph
node
glandular
mucos
tissu
shown
seed
lacrim
gland
montgomeri
et
al
montgomeri
et
al
manner
similar
effecto
r
site
mucos
immun
system
roux
et
al
mcdermott
bienenstock
weiszcarringto
n
et
al
tear
iga
antibodi
specif
ora
l
microb
burn
et
gregori
allansmith
franklin
montgomeri
publish
courtesi
mosbi
well
demonstr
gastrointestin
immun
induc
tear
iga
antibodi
mestecki
et
al
montgomeri
et
gregori
filler
waldman
bergmann
provid
support
linkag
figur
show
interrelationship
variou
compart
f
mucos
network
summar
event
lead
mucos
iga
induct
follow
galt
immun
mechan
account
preferenti
local
retent
specif
lymphoid
popul
ocular
mucos
tissu
issu
central
import
understand
regul
ocular
mucosa
l
immun
lymphocytehigh
endotheli
venul
hev
interact
control
lymphocyt
traffick
organ
lymphoid
tissu
lymph
node
butcher
woodruff
et
al
stoolman
chin
et
picker
butcher
shimizu
et
bevilacqua
well
organ
mucosa
l
lymphoid
tissu
jalkanen
et
chin
et
gener
interact
involv
lymphocyt
home
receptor
interact
vascular
addressin
hev
special
endotheli
cell
although
littl
known
regard
mechan
involv
cell
traffick
conjunctiv
tissu
paramet
regul
lymphocyt
local
within
lacrim
gland
begin
defin
wit
h
respect
glandular
structur
control
lymphocyt
traffic
could
occur
two
level
exit
montgomeri
et
al
publish
courtesi
f
plenum
vasculatur
within
stroma
glandula
r
tissu
hev
lacrim
gland
n
select
interact
glandular
endothelium
hav
e
yet
demonstr
therefor
appear
lymphocyt
entri
lacrim
gland
random
mcge
e
franklin
current
evid
suggest
lymphocyt
popul
select
retain
base
interact
occur
within
lacrim
tissu
microenviron
earli
studi
indic
bcell
retent
particularli
commit
iga
product
result
direct
interact
cell
locat
n
lacrim
tissu
franklin
shepard
recent
vitro
bind
assay
use
show
tha
circul
lymphocyt
popul
preferenti
adher
lacrim
gland
acinar
epithelium
sullivan
b
lymphocyt
particip
interact
b
cell
bind
great
r
number
sullivan
et
studi
biochem
inhibitor
antibodi
direct
variou
adhes
molecul
initi
suggest
involv
lselectin
sullivan
et
b
data
indic
pretreat
lymphocyt
wit
h
certain
cytokin
tgfp
reduc
capac
cell
interact
lacrim
gland
lymph
node
peyer
patch
elfaki
et
latter
data
provid
initi
support
th
e
involv
receptor
distinct
mediatin
g
interact
lymph
node
peyer
patch
hev
character
lymphocyt
receptor
stil
l
ongo
factor
identifi
whic
h
specif
inhibit
lymphocyt
interact
lacrim
salivari
gland
tissu
montgomeri
liberati
current
studi
focus
defin
th
e
relationship
molecul
lymphocyt
surfac
determin
adhes
molecul
well
n
identif
acinar
epitheli
cell
ligand
r
counter
receptor
respect
ligand
recen
studi
use
cultur
rat
lacrim
gland
acinar
cell
suggest
molecul
shed
cultur
medium
sullivan
et
led
specul
traffick
lymphocyt
may
also
interact
wit
h
secret
ligand
access
interstiti
glandular
space
although
ligand
counter
receptor
yet
isol
appear
glycoprotein
r
raja
p
c
montgomeri
unpublish
observ
regulatori
event
lead
induct
express
ocular
mucos
immun
respons
complet
defin
howev
clear
mani
factor
govern
immun
respons
mucos
site
kiyono
et
walker
gener
applic
mucos
immun
respons
ocular
surfac
immun
rout
primari
importanc
e
local
e
g
topic
applic
eye
remot
site
e
g
oral
gastrointestin
rout
gener
tear
iga
antibodi
respons
combin
rout
sequenc
administr
also
affect
antibodi
induct
tear
surprisingli
replic
microb
tissu
tropism
invas
properti
influenc
outcom
mucos
respons
dealin
g
nonrepl
immunogen
particul
antigen
effect
induc
ocular
mucos
immun
e
respons
solubl
antigen
thu
far
tradit
mucos
adjuv
cholera
toxin
deliv
topic
eye
antigen
appear
enhanc
e
ocular
antibodi
respons
helper
th
cell
tcell
product
cytokin
appear
play
key
role
regul
ocula
r
mucos
iga
respons
direct
role
cytotox
tc
cell
ocular
mucos
immun
current
clear
note
see
section
ii
b
lymphocyt
traffic
mucos
induct
effector
site
centra
l
featur
ocular
mucos
system
antigenpres
cell
e
g
macrophag
dendrit
cell
al
requir
particip
ocular
mucos
respons
yet
delin
neuroendocrin
e
system
also
play
role
regul
ocular
mucosa
l
respons
affect
secretori
compon
synthesi
vivo
sullivan
et
al
cultur
lacrima
l
gland
acinar
cell
well
tear
iga
product
sullivan
neuroendocrin
regul
review
n
detail
elsewher
stanisz
et
al
sullivan
although
well
factor
yet
b
e
identifi
impact
ocular
mucos
immun
respons
focu
select
paramet
relev
th
e
develop
ocular
vaccin
strategi
therefor
effect
immun
rout
immun
potenti
deliveri
vehicl
induct
ocular
mucosa
l
respons
particular
iga
antibodi
product
b
e
examin
detail
human
investig
focus
use
f
oral
gastrointestin
gi
immun
rout
ingest
heatkil
streptococcu
mutan
elicit
iga
antibodi
tear
saliva
serum
antibodi
mestecki
et
al
addit
second
oral
immun
markedli
increas
tear
salivari
iga
respons
studi
use
inactiv
mutan
gener
confirm
initi
observ
gregori
et
al
gregori
filler
czerkinski
et
al
human
tear
iga
antibodi
respons
al
note
follow
oral
immun
influenz
vaccin
bergmann
et
al
waldman
bergmann
well
follow
intranas
immun
live
rhinoviru
dougla
et
al
knopf
et
al
rat
model
employ
directli
compar
effect
antigen
applic
conjunctiva
ocular
topic
ot
administr
oral
gastrointestin
gi
rout
use
nonrepl
particul
antigen
dinitrophenyl
type
iii
pneumococcu
dnppn
studi
shown
immun
rout
sequenc
stimul
play
role
tear
antibodi
express
montgomeri
et
al
longterm
repeat
ot
stimulatio
n
lead
eventu
downregul
tear
iga
antibod
level
montgomeri
et
al
b
ot
rout
e
gener
yield
higher
tear
iga
antibodi
level
g
immun
peppard
et
al
coadministr
antigen
cytokin
ot
rout
enhanc
tear
iga
antibodi
level
pockley
montgomeri
see
section
iii
b
rat
model
also
ha
use
studi
effect
immun
rout
n
kinet
serum
tear
antibodi
respons
liv
e
chlamydia
trachomati
davidson
et
al
thi
studi
compar
effect
ot
gi
subconjunctiv
intraperiton
immun
show
ot
applic
effect
rout
elicit
iga
antibodi
respons
tear
interestingli
subconjunctiv
inject
chlamydia
yield
vigor
serum
igg
respons
minim
tear
iga
antibodi
consist
respons
antigen
deliv
rout
cousin
et
al
explan
latter
find
clear
subconjunctiv
deliveri
may
bypass
essenti
ocular
mucos
process
step
antigen
uptak
allow
liv
e
organ
gain
access
circul
although
precis
mechan
ot
immun
elicit
tear
iga
antibodi
respons
known
appear
induct
process
could
involv
least
two
pathway
antigen
uptak
process
trigger
b
cell
conjunctiv
substantia
propria
antigen
drainag
via
nasolacrima
l
canal
uptak
nalt
cell
process
trigger
resid
b
cell
nalt
carr
et
al
submit
schemat
detail
two
pathway
show
n
fig
shown
figur
option
fo
r
antigen
drainag
via
nasolacrim
canal
acc
galt
altern
may
applic
primat
human
monkey
antigen
may
reac
h
accessori
lacrim
gland
directli
gain
access
potenti
ductal
associ
lymphoid
tissu
bee
n
shown
minor
salivari
gland
nair
schroeder
howev
sinc
clear
antigen
woul
process
within
acinar
unit
accessor
lacrim
gland
ductalassoci
lymphoid
tissu
e
identifi
glandular
structur
latter
altern
appear
unlik
sever
anim
model
also
use
eval
uat
tear
antibodi
respons
immun
infect
ocular
surfac
chlamydia
oth
r
pathogen
guinea
pig
ocular
immun
live
chlamydia
psittaci
gpic
induc
tear
ig
case
igg
antibodi
murray
et
al
watson
et
al
rank
whittumhudson
kill
organ
administ
via
ocular
topic
murray
et
al
intraperiton
rout
malati
et
al
fail
induc
tear
antibodi
howev
similar
studi
human
biovar
c
trachomati
n
owl
monkey
suggest
inactiv
chlamydia
coul
inde
induc
tear
antibodi
macdonald
et
al
cynomolgu
monkey
model
ocular
infect
chlamydi
organ
induc
vigor
iga
igg
igm
respons
serum
tear
review
b
taylor
oral
immun
live
l
biovar
chlamydia
ocular
serotyp
successful
induc
mucos
system
immun
partial
protect
host
subsequ
infecti
challeng
taylor
et
al
cynomolgu
monkey
develop
conjunctiv
diseas
similar
observ
human
whittumhudson
taylor
intens
mononuclear
infiltr
appear
infect
conjunctiva
whittumhudso
n
et
al
b
whittumhudson
taylor
compos
high
frequenc
chlamydiaspecif
b
lymphocyt
pal
et
al
support
th
e
import
region
drain
cervic
lymph
node
n
conjunctiv
respons
pathogen
essenti
ident
frequenc
antigenspecif
cell
detect
n
lymph
node
conjunctiva
infect
ocularimmun
anim
topical
challeng
chlamydi
antigen
pal
e
al
pal
e
al
serolog
respons
chlamydia
l
vigor
chronic
chlamydi
infect
man
anim
newhal
e
al
pal
et
al
although
neither
protein
deliv
ot
rout
immun
naiv
monkey
taylor
et
taylor
et
contrast
ot
boost
system
oral
immun
purifi
r
recombin
chlamydi
antigen
induc
vigor
tea
r
iga
igg
serum
antibodi
campo
et
al
brien
et
al
remain
unclear
whether
th
e
initi
dosag
antigen
small
induc
e
typic
primari
secretori
immun
respons
present
mucos
immun
system
ot
deliveri
r
antigen
must
replic
andor
invas
adequ
prime
experiment
anim
nevertheless
ocular
boost
purifi
antigen
infecti
ocula
r
challeng
system
prime
anim
demonstr
anamnest
tear
antibodi
respons
occu
r
rapidli
chlamydia
campo
et
al
combin
oral
subcutan
prime
chlamydi
fusio
n
protein
major
outer
membran
protein
momp
variabl
domain
incorpor
liposom
also
prime
mucos
immun
respons
rabbit
model
also
use
test
ocula
r
immun
respons
organ
live
herp
simplex
viru
type
administ
ocular
rout
e
elicit
tear
iga
igg
igm
antibodi
will
et
al
contrast
applic
scarifi
corn
induc
tear
iga
igg
igm
respons
centifanto
et
whether
differ
result
relat
viru
strain
invas
access
underli
dendriti
c
cell
unclear
live
staphylococcu
aureu
administ
ot
elicit
tear
iga
igg
antibodi
aureu
subunit
peptidoglycanribitol
teichoic
acid
vaccin
administ
intraderm
subconjunctiva
l
rout
complet
freund
adjuv
mondino
et
al
mondino
et
al
b
howev
given
sever
inflammatori
properti
freund
adjuv
restrict
use
latter
approach
impract
vaccin
strategi
immun
potenti
adjuv
use
enhanc
antibodi
respons
human
anim
model
although
mechan
respons
respons
enhanc
vari
often
well
de
l
fine
adjuv
appear
function
one
combin
mechan
increas
influx
inflammatori
cell
promot
antigen
present
andor
enhanc
antigen
uptak
consider
f
immun
potenti
enhanc
ocular
mucos
respons
requir
select
compound
promot
ocular
inflamm
patholog
wide
studi
mucos
adjuv
ha
cholera
toxin
lyck
holmgren
although
effect
ocular
immun
less
defin
enhanc
mucos
respons
depend
th
e
bind
cholera
toxin
b
subunit
g
gangliosid
display
lumin
surfac
enterocyt
cell
well
potenti
modulatori
effect
toxin
b
antigenpres
cell
dertzbaugh
elson
elson
dertzbaugh
cholera
toxin
enhanc
antibodi
respons
coadminist
mani
antigen
wherea
th
e
b
subunit
appar
requir
conjug
antigen
function
optim
oral
immun
cholera
toxin
induc
appear
toxinspecif
antibodyform
cell
rat
conjunctiva
zhang
et
al
toxinspecif
antibodi
tear
monkey
campo
e
al
howev
ot
administr
cholera
toxi
n
dnppn
antigen
enhanc
tear
iga
antibodi
respons
rat
model
effect
oral
ocular
administr
antigen
conjug
b
subunit
tea
r
iga
respons
fulli
investig
base
recent
data
suggest
nasal
associ
lymphoid
tissu
serv
induct
site
tear
iga
antibodi
respons
carr
et
al
submit
abil
b
subunit
serv
adjuv
coupl
antigen
administ
intranas
rout
bessen
fischetti
wu
russel
immun
protocol
requir
rigor
test
two
mucos
adjuv
avridin
muramyl
tripeptid
administ
topic
ocular
rout
dnppn
enhanc
tear
iga
antibodi
respons
peppard
e
al
cytokin
also
appear
exert
import
regulatori
effect
mucos
iga
respons
includ
ocular
site
interleukin
il
knockout
mice
greatli
reduc
number
iga
produc
cell
mucosa
exhibit
grossli
defici
local
antibodi
respons
mucos
challeng
ramsay
et
al
n
addit
transform
growth
factora
tgf
shown
enhanc
vitro
iga
respons
murin
bcell
cultur
appear
increas
iga
synthesi
induc
b
cell
switch
ig
product
coffman
et
al
ehrhardt
et
al
wherea
induc
iga
b
cell
termin
differenti
iga
produc
plasma
cell
coffman
et
al
beagley
et
al
beagley
et
al
harriman
et
al
bee
n
shown
specif
enhanc
iga
product
vitro
rat
lacrim
gland
tissu
fragment
cultur
syst
pockley
montgomeri
rafferti
montgomeri
combin
antigen
shown
enhanc
specif
tear
iga
antibodi
respons
rat
follow
ot
administr
without
affect
serum
igg
antibodi
level
pockley
montgomeri
recent
studi
indic
enhanc
tear
iga
antibodi
respons
persist
follow
restimul
antigen
absenc
f
montgomeri
et
al
although
th
e
mechan
underli
vivo
cytokinemedi
enhanc
yet
known
clear
regulatori
role
therapeut
potenti
oth
r
cytokin
modul
ocular
mucos
antibodi
respons
requir
investig
although
oral
gi
immun
rout
trigger
iga
antibodi
respons
intestin
distal
mucosa
l
site
repres
safe
conveni
altern
vaccin
administr
often
difficult
presen
intact
antigen
galtinduct
site
particul
antigen
includ
viabl
organ
gener
appear
b
e
effect
immunogen
probabl
due
abil
surviv
ph
extrem
enzymat
degrad
occur
along
alimentari
tract
sinc
man
potenti
vaccin
candid
microbi
compon
subunit
viabl
organ
particulat
e
immunogen
consider
effort
focus
develop
deliveri
system
deliveri
system
includ
liposom
biodegrad
microparticl
well
recombin
bacteri
viral
vector
strategi
vehicl
develop
includ
deliveri
intact
immunogen
gene
code
fo
r
relev
antigen
also
system
promot
uptak
relev
cell
e
g
cell
galt
induct
site
detail
inform
antigen
deliveri
system
b
e
found
sever
recent
review
eldridg
et
al
michalek
et
al
michalek
et
al
although
mani
deliveri
system
may
relev
induct
f
mucos
antibodi
respons
owe
abil
induc
vigor
respons
galt
effector
site
inform
limit
potenti
employ
the
e
vehicl
induc
ocular
mucos
immun
respons
base
recent
observ
indic
microparticleencapsul
antigen
evok
ocular
mucos
respons
discuss
confin
deliveri
vehicl
poli
lactidecoglycolid
plg
microparticl
ar
e
biodegrad
physiolog
condit
repres
import
candid
vehicl
deliveri
control
releas
vaccin
compon
hagan
et
al
plg
use
sutur
materi
wise
et
al
deliveri
syst
drug
hutchinson
furr
plg
evok
tissu
respons
visscher
et
al
ha
certifi
fda
human
use
recent
plg
microparticl
use
ocular
drug
deliveri
without
provok
histolog
electrophysiolog
chang
eye
moritera
et
al
addit
plg
encapsul
antigen
induc
sustain
system
secretori
immun
respons
follow
ora
l
administr
challacomb
et
al
maloy
et
al
base
data
well
observ
tha
cytokin
enhanc
tear
iga
antibod
respons
follow
topic
applic
eye
pockley
montgomeri
see
section
iii
b
plg
microparticl
appear
appropri
vehicl
deliv
antigen
immun
potenti
ocular
mucosa
l
induct
site
studi
indic
dnpbovin
serum
albumin
well
encapsul
plg
microparticl
without
signific
loss
f
activ
addit
deliveri
encapsul
antig
n
cytokin
evok
longterm
mucos
antibodi
respons
tear
distal
secret
well
circul
antibodi
rat
model
rafferti
et
al
oral
deliveri
poli
lactid
encapsul
chlamydia
candid
vaccin
mice
induc
antig
n
specif
serolog
respons
confer
partial
protect
ocular
challeng
whittumhudson
et
al
see
section
iv
studi
ar
e
requir
defin
regulatori
paramet
event
lead
respons
microparticl
clearli
ar
e
promis
candid
deliveri
vehicl
elicit
ocula
r
mucos
immun
respons
conjunctiva
commonli
infect
tissu
f
eye
sy
hyndiuk
tabbara
hyndiuk
infect
may
limit
conjunctiv
may
part
lid
corneal
infect
mo
conjunctiv
infect
visionthreaten
bu
notabl
except
neisseria
gonorrhea
herp
simplex
viru
conjunct
associ
tularemia
adult
knorr
weber
haemophilu
infect
infant
sy
hyndiuk
potenti
fatal
system
dissemin
profil
pathogen
isol
normal
diseas
human
conjunctiva
may
vari
depend
upon
geograph
local
sy
hyndiuk
similarli
veterinari
pathogen
conjunctivalacrima
l
gland
geograph
confin
lepper
et
al
roger
et
al
chronic
inflamm
conjunctiva
may
lead
scar
format
term
chronic
progress
conjunctiv
cicatris
bernauer
et
al
cicatrici
diseas
often
progress
involv
th
e
lacrim
meibomian
gland
combin
alter
tear
film
scar
contract
corneal
trauma
trichiasi
may
lead
blind
although
noninfecti
etiolog
mani
cicatr
disord
includ
pemphigoid
chlamydi
infect
th
e
conjunctiva
classic
exampl
blind
sequela
infect
discuss
elsewher
physic
biochem
barrier
help
prevent
ocular
infect
extracellular
ocula
r
bacteri
infect
antibodi
major
componen
protect
immun
antibodi
cellmedi
immun
believ
import
protect
intracellular
pathogen
includ
virus
chlamydia
mycobacteria
antibodi
would
block
infect
clear
free
organ
wherea
cytotox
cell
would
clear
infect
cell
prevent
ful
l
differenti
spread
lyse
host
cell
littl
vivo
evid
ocular
site
cytotox
lymphocyt
import
clearanc
infecti
pathogen
howev
cell
serv
antigen
present
cell
bcell
respons
cell
produc
cytokin
facilit
ban
tcell
respons
mani
bacteria
virus
parasit
target
vaccin
develop
prevent
respiratori
genit
tract
infect
protect
mucos
immun
induc
one
the
e
latter
site
probabl
ocular
mucos
surfac
would
also
protect
varieti
bacteria
infect
ocular
tissu
tabl
list
bacteri
pathogen
known
caus
conjunct
bacteri
conjunct
mo
commonli
caus
aureu
streptococcu
sp
ar
e
common
conjunctiv
pathogen
except
c
streptococci
pyogen
member
thi
group
part
normal
conjunctiv
flora
the
e
bacteria
haemophilu
influenza
common
agent
caus
dacryocyst
lacrim
gland
infect
corynebacterium
diphtheria
rare
ocula
r
pathogen
caus
conjunctiv
scar
associ
problem
part
bacteri
infect
conjunctiva
selflimit
nonvis
threaten
neisseria
gonorrhoea
except
organ
lead
caus
hyperacut
conjunct
particularli
develop
countri
sy
hyndiuk
n
mening
conjunct
whic
h
distinguish
clinic
n
gonorrhoea
also
may
associ
system
diseas
h
influenza
conjunct
occur
children
well
adult
one
could
predict
declin
incid
thi
ocular
diseas
hib
vaccin
avail
anaerob
organ
compos
anoth
part
normal
flora
conjunctiv
sac
infecti
pathogen
incid
conjunctiv
infect
abnorm
anaerob
organ
increas
patient
aaberg
zaidman
knorr
weber
will
et
al
taylor
et
al
heggi
lass
brunha
peel
dhingra
mahajan
king
et
al
brook
hulburd
lind
et
al
young
zundel
et
al
select
primari
articl
andor
review
bacteri
ocula
r
pathogen
may
caus
conjunct
usual
associ
corneal
infect
follow
abras
tissu
injuri
hazlett
et
al
ramphal
et
al
guinea
pig
ocular
challeng
model
use
test
protect
immun
induc
antishigella
vaccin
corneal
conjunctiv
epithelium
similar
intestin
epithelium
suscept
invas
shigella
infect
conjunctiv
mucosa
problem
fo
r
abort
ewe
goat
howev
vaccin
via
conjunctiv
reduc
spontan
abort
compar
system
immun
aid
dugel
rao
campo
et
al
similarli
case
microsporidi
conjunct
report
aid
patient
lacey
et
al
lowder
weber
et
al
chlamydia
trachomati
oblig
intracellula
r
bacterium
receiv
great
deal
attent
respect
vaccin
develop
chlamydia
ha
gain
notorieti
recent
year
major
sexual
transmit
pathogen
fact
lead
caus
f
prevent
blind
trachoma
result
chronic
chlamydi
infect
conjunctiva
bee
n
known
sinc
ancient
time
studi
patient
sever
endem
area
worldwid
yield
valuabl
informatio
n
regard
epidemiolog
microbiolog
serolog
characterist
trachoma
nichol
et
al
grayston
et
al
dawson
et
al
mabey
et
al
taylor
et
al
two
major
anim
model
use
immunolog
studi
chlamydia
l
ocular
infect
guinea
pig
model
infect
c
psittaci
caus
guinea
pig
inclus
conjunct
gpic
subhuman
primat
includin
g
owl
monkey
cynomolgu
monkey
b
e
infect
sever
biovar
c
trachomati
usual
human
ocular
pathogen
patton
rank
whittumhudson
recent
mous
model
ocular
infect
develop
use
human
ocula
r
biovar
whittumhudson
et
al
mode
l
aid
immunolog
studi
bee
n
possibl
outbr
speci
vaccin
develop
bacterium
bee
n
hamper
sever
key
factor
protect
antigen
epitop
conclus
identifi
fro
plethora
immunogen
protein
chlamydi
target
antigen
shown
convincingli
express
surfac
infect
host
cell
chlamydiainduc
diseas
sequela
immunemedi
though
chlamydi
heatshock
protein
associ
immunopathogen
respons
watkin
et
al
taylor
et
al
morrison
et
al
b
variou
permut
chlamydi
major
outer
membran
protein
momp
test
fo
r
immunogen
abil
induc
protectiv
e
immun
experiment
anim
biochem
extract
nativ
momp
recombin
momp
variabl
domain
present
system
mucos
rout
case
protect
test
b
infecti
challeng
ocular
mucos
surfac
r
site
genit
tract
lung
etc
tabl
ii
list
som
e
chlamydi
vaccin
candid
test
experiment
past
two
decad
case
whol
e
momp
subunit
highli
immunogen
measur
primarili
serolog
respons
signific
vivo
protect
ocular
infect
observ
direct
immun
studi
sever
group
ward
et
al
mabey
et
al
stagg
et
al
murdin
et
al
murdin
et
al
tuffrey
identifi
import
momp
peptid
epitop
immun
respons
induc
none
test
ocular
infect
model
yet
sever
lea
partial
protect
chlamydi
genit
infect
model
review
tuffrey
chlamydi
antigen
chlamydi
lipopolysaccharid
lp
shown
immunogen
protect
ocular
infect
model
taylor
prendergast
additiona
l
chlamydi
antigen
exoglycolipid
antigen
glxa
stuart
macdonald
also
express
b
chlamydia
secret
infect
cell
vitro
stuart
et
al
wyrick
et
al
monoclon
antiidiotyp
id
antibodi
glxa
bee
n
shown
immun
protect
mice
subsequ
infecti
ocular
challeng
human
biovar
chlamydia
oral
immun
balbc
mice
poli
lactid
encapsul
antiid
antibodi
glxa
shown
recent
even
protect
solubl
antibodi
sinc
e
less
antibodi
present
microspher
induc
equival
better
reduct
microbiolog
diseas
case
mice
develop
serum
antibodi
th
e
holzberg
et
al
sy
hyndiuk
murphi
et
al
sy
hyndiuk
pal
et
al
taylor
et
al
b
grayston
et
al
nichol
et
al
nichol
et
al
soldati
et
al
schachter
taylor
et
al
taylor
et
al
batteig
et
al
campo
et
al
campo
et
al
wong
et
al
taylor
et
al
tuffrey
allen
stephen
brien
et
al
whittumhudson
et
al
hay
et
al
murdin
et
al
taylor
et
al
taylor
et
al
rank
et
al
whittumhudson
taylor
whittumhudso
n
et
al
b
glxa
antibodi
neutral
vitro
infect
whittumhudson
et
al
whittumhudson
et
al
submit
type
vaccin
approac
h
potenti
valu
chlamydi
infect
oth
r
site
biovar
sinc
glxa
antig
n
genusspecif
oppos
serovarspecif
hypothes
sever
investig
protect
immun
chlamydia
requir
e
induct
neutral
antibodi
tear
assum
siga
iga
tear
patient
trachoma
passiv
neutral
chlamydia
reduc
diseas
eye
owl
monkey
nichol
et
al
barenfang
macdonald
wa
consist
observ
guinea
pig
ocularli
infect
c
psittaci
orenstein
et
al
malati
et
al
dilemma
chlamydi
pathogen
individu
previou
ocular
site
infect
chlamydia
significantl
protect
subsequ
ocular
infect
thi
lack
protect
immun
seen
despit
evid
vigor
antibodi
respons
mani
chlamydi
anti
gen
tear
serum
vitro
lymphocyt
prolif
respons
whole
organ
purifi
antigen
newhal
et
al
ward
et
whittumhudson
taylor
taylor
sever
clinic
studi
shown
poor
correl
acquisit
f
genit
chlamydi
infect
presenc
neutral
serum
antibodi
jone
van
der
poi
cytotox
cell
yet
associ
directli
ocular
protect
immun
immunopathogenesi
chlamydia
ocular
infect
ha
argu
lack
exposur
chlamydi
antigen
surfac
infect
host
cell
would
prevent
serv
immunolog
target
explain
failur
induc
tcellmedi
immun
howev
recent
electron
microscop
studi
huma
n
endometri
cell
shown
chlamydi
momp
lp
glxa
wyrick
et
al
pass
fro
inclus
bodi
cytoplasm
cel
l
membran
lp
glxa
known
exit
infect
cell
brade
et
al
stuart
et
al
lukacova
et
addit
recent
studi
demonstr
mediat
cytotox
kill
chlamydiaprim
cell
vitro
vivo
protect
experiment
genit
infect
beatti
stephen
starnbach
et
thu
possibl
chlamydi
antigen
present
effector
cell
may
occur
context
mhc
class
b
viral
parasit
infect
tabl
iii
list
mani
viral
parasit
pathogen
known
infect
ocular
tissu
respect
virus
infect
frequent
result
conjunct
n
children
adult
highli
contagi
infect
epidem
keratoconjunct
resolv
spontan
week
common
vira
l
pathogen
conjunctiva
adenoviru
sever
adenoviru
type
may
associ
conjunct
though
corneal
involv
often
see
n
hurrah
ocular
herpesviru
infect
though
oft
n
affect
cornea
may
caus
conjunct
durin
g
primari
infect
howev
conjunct
rare
durin
g
recurr
infect
herp
simplex
viru
holzber
g
et
herp
zoster
ophthalmicu
may
develo
p
patient
latent
varicellazost
viru
infect
conjunctivia
one
sever
ocular
site
mo
often
affect
liesegang
sinc
present
ther
e
vaccin
herpesvirus
antivir
drug
remai
n
therapeut
option
larg
literatur
concern
antiherpesviru
vaccin
develop
strate
gie
inform
detail
sever
review
rous
lopez
dix
mader
stult
stanberri
addit
fact
tha
herpesvirus
ubiquit
major
f
individu
expos
previous
vaccin
develop
strategi
ocular
extraocular
herp
viru
infect
must
deal
number
question
recurr
latent
infect
ablat
vaccin
must
primari
infect
prevent
herpesvirusinduc
immunosuppress
overcom
appropri
immun
combin
subunit
vaccin
requir
system
rather
mucos
immun
requir
tabl
v
list
recent
herp
simplex
viru
vaccin
candid
number
viral
glycoprotein
target
vaccin
e
g
burk
et
al
although
exampl
better
protect
confer
vaccin
live
organ
ghiasi
et
al
studi
directli
test
protectio
n
ocular
herp
simplex
viru
infect
use
variou
viral
construct
rang
singl
multipl
e
glycoprotein
construct
delet
mutant
deliver
without
adjuv
avirul
construct
hav
e
test
varieti
experiment
model
clinic
trial
immun
via
system
rout
subcutan
intraperiton
recen
studi
use
rabbit
model
recurr
ocular
herp
infect
show
subconjunctiv
immunizatio
n
recombin
gb
gd
establish
latent
infect
reduc
spontan
recurr
nesburn
et
promis
result
bee
n
wickham
et
al
sy
hyndiuk
tabarra
hyndiuk
huang
et
al
pepos
holzberg
et
al
pepos
holzberg
et
al
sy
hyndiuk
mcdonnel
et
al
sy
hyndiuk
conway
et
al
callanan
et
al
taylor
gori
scasso
vaccin
e
purifi
synthet
glycoprotein
gb
gc
gb
gc
g
baculovirusexpress
glycoprotein
gb
gi
gc
ge
gg
andor
g
h
adenovirusexpress
glycoprotein
gb
vaccina
virusexpress
glycoprotein
refer
chan
robert
et
al
long
et
al
dix
mill
ishizaka
mishkin
burk
et
al
ghiasi
et
al
nesburn
et
al
gallichan
et
al
aurelian
et
al
rooney
et
al
bank
et
al
flec
k
et
al
farrel
et
al
cantin
et
al
select
primari
articl
andor
review
nonbacteri
ocular
pathogen
b
infect
replic
cultur
rat
lacrim
gland
acina
r
cell
capac
infect
vivo
known
delet
mutant
gh
antisens
nucleic
acid
select
refer
see
also
rous
lopez
dix
mader
stult
stanberri
shown
extraocular
infect
model
sever
group
includ
strategi
mucos
vaccinatio
n
recombin
adenoviru
express
herp
simpl
x
viru
gb
gallichan
et
subcutan
immun
viru
construct
miss
essenti
glycoprotein
e
g
gh
farrel
et
al
system
deliveri
synthet
peptid
approach
includ
use
antisens
nucleic
acid
cantin
et
al
use
express
system
e
g
baculoviru
vaccinia
recent
studi
cytokin
respons
associ
vivo
vitro
antivir
protect
implic
tnfa
either
recoveri
reduc
herp
infect
che
n
et
tumpey
et
al
babu
et
al
investig
requir
distinguish
tcellmedi
immunopatholog
effect
newel
et
al
hendrick
tumpey
hendrick
et
al
potenti
requiremen
individu
tcell
subset
vaccineinduc
immun
sever
common
parasit
infect
may
cau
e
conjunct
includ
mulluscum
contagiosum
onchocerca
vulva
verruca
vulgari
trypanosom
cruzi
case
conjunctiv
mucosa
may
b
e
portal
entri
e
g
cruzi
patholog
result
trypanosomiasi
includ
oculoglandular
ophthalmoganglionar
complex
compos
lid
edema
granulomat
conjunct
follicl
inflamm
lacrim
gland
parinaud
oculoglandular
syndrom
rare
may
also
caus
additiona
l
viral
bacteri
agent
e
g
f
tularensi
tuberculosi
sy
hynduik
experiment
model
conjunctiv
lacrima
l
gland
infect
use
mani
year
identifi
pathogen
protect
immun
respons
recent
evalu
vaccin
candid
recent
advanc
includ
new
rat
rabbit
model
adenoviru
ocular
infect
help
evalu
immunemedi
respons
pathogen
tsai
et
al
gordon
et
al
clear
event
take
place
conjunctiva
l
tissu
lacrim
gland
relev
ocular
mucosa
l
vaccin
strategi
lacrim
gland
function
primari
effector
site
mucos
iga
antibod
respons
precis
relationship
conjunctiva
mucos
network
requir
studi
appear
conjunctiva
play
role
induct
f
mucos
antibodi
respons
well
serv
effector
site
cellmedi
respons
varieti
factor
involv
regul
ocular
mucosa
l
antibodi
respons
mani
option
immun
rout
deliveri
vehicl
immun
potentia
tor
investig
although
develop
appropri
immun
strategi
depend
n
properti
potenti
vaccin
candid
well
target
ocular
pathogen
appropri
technolog
avail
elicit
mucos
antibodi
respons
ocular
surfac
current
challeng
identifi
select
vaccin
compon
ca
n
use
elicit
longterm
protect
respons
ocula
r
pathogen
studi
laboratori
summar
n
chapter
support
part
nih
grant
edna
mc
connel
clark
foundat
grant
author
thank
linda
hazlett
nanci
sullivan
robert
prendergast
robert
swanborg
fo
r
critic
assess
chapter
nanci
hynou
secretari
support
aaberg
expand
ophthalmolog
spectrum
lyme
diseas
j
ophthalmol
allansmith
r
kajiyama
g
abelson
b
simon
plasma
cell
content
main
accessori
lacrim
gland
conjunctiva
j
ophthalmol
allansmith
r
korb
r
greiner
j
v
henriquez
simon
finnemor
v
giant
papillari
conjunct
contact
len
wearer
j
ophthalmol
allen
j
e
stephen
r
intermolecula
r
mechan
cell
help
product
antibodi
bacteri
pathogen
chlamydia
trachomati
eur
j
immunol
aurelian
l
smith
c
c
wachsman
paoletti
e
immun
respons
herp
simplex
viru
n
guinea
pig
footpad
model
mice
immun
vaccinia
viru
recombin
contain
herp
simpl
x
viru
glycoprotein
rev
infect
di
babu
j
kanangat
rous
b
cell
cytokin
mrna
express
cours
immunopatholog
ocular
diseas
herpet
stromal
kerat
j
immunol
bank
jenkin
f
j
kanagat
nair
dasgupta
foster
c
rous
b
vaccinatio
n
immediateearli
protein
herp
simplex
virustyp
induc
virusspecif
lymphoprolifer
fail
protect
lethal
challeng
virolog
barenfang
j
macdonald
b
role
immunoglobulin
neutral
trachoma
infect
j
immunol
immunol
batteig
b
e
rank
r
g
bavoil
p
soderberg
